Hemab Therapeutics Holdings COAG
NASDAQ COAG
$40.86 +1.48 (+3.76%)
At close: Nov 13, 2026 · 4:00 PM EST

Hemab Therapeutics Holdings (COAG) Shares Outstanding (Diluted) (2025 - 2026)

Updated

Analysis

Hemab Therapeutics Holdings (COAG) Shares Outstanding (Diluted) (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 893.40 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 2.45 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 1.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 2.48 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 1.96 Bn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 1.56 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 546.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 1.25 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 5.75 Bn
10 Hemab Therapeutics Holdings 1.91 Bn 672.70 Mn - 46.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 46.71 Mn
Jun 30, 2026 30.11 Mn
Mar 31, 2026 946,000.00
Dec 31, 2025 946,000.00
Sep 30, 2025 946,000.00
Jun 30, 2025 946,000.00
Mar 31, 2025 946,000.00
API Access

Hemab Therapeutics Holdings Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=COAG&period=max&api_key=YOUR_API_KEY